Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA kicks off “new era” in China

This article was originally published in The Tan Sheet

Executive Summary

Health and Human Services Secretary Mike Leavitt opens FDA offices in China at the U.S. Embassy in Beijing, the U.S. Consulate General in Guangzhou and the U.S. consular mission in Shanghai, HHS says Nov. 18. "We're opening up a new era, not just new offices," Leavitt says, adding that eight senior agency officials in China will "ensure that quality and safety are built into food and consumer products at the point of manufacture." The U.S.-China partnership stems from a 2007 memorandum of agreement (1"The Tan Sheet" March 24, 2008, p. 16). HHS says FDA will have a presence in the Middle East, India, Europe and Latin America

You may also be interested in...



China to open U.S. inspection office

China sends food and drug inspectors to the U.S. as part of a December 2007 agreement to "promote the two countries' exchanges and cooperation in product quality, medical service and food safety," the Chinese Ministry of Foreign Affairs says. The announcement comes shortly after FDA established offices in Beijing, Shanghai and Guangzhou, China (1"The Tan Sheet" Nov. 24, 2008, In Brief). China is contemplating the details of sending staff to the U.S., says the Chinese Embassy in Washington

FDA Plans Offices In China As Heparin Case Unfolds, With India On Deck

FDA is moving rapidly to establish offices in Asia, with firm plans developing in China, and India next in line

Investors Go Beserk For Viking, Putting It Top Of Q1 Winners

The top 10 biggest share price winners and losers in Q1 from Evaluate show the investor frenzy for obesity drugs continues, while companies with governance doubts see shareholders retreat.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS102331

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel